Showing results (281-290 of 383) with videos related to

Sort By:
Pageof 39
The Annals of Thoracic Surgery|October 1, 1988
Transatrial repair of double-chambered right ventricleD K Ford, C A Bullaboy, W M Derkac, et al.
Investigational New Drugs|April 9, 2001
A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapyJ E Dowell, D H Johnson, J S Rogers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancerD H Johnson, M J DeLeo, K R Hande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancerA F List, J D Hainsworth, B W Davis, et al.
The American Journal of Medicine|December 1, 1986
Acute nonlymphocytic leukemia after treatment of small cell lung cancerD H Johnson, L L Porter, A F List, et al.
American Journal of Human Genetics|May 11, 1992
Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: first report of the WS consortiumL A Farrer, K M Grundfast, J Amos, et al.
Clinical Genetics|September 20, 2007
Identities, frequencies and origins of TMC1 mutations causing DFNB7/B11 deafness in PakistanS-I Kitajiri, R McNamara, T Makishima, et al.
American Journal of Human Genetics|June 9, 2001
Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1FZ M Ahmed, S Riazuddin, S L Bernstein, et al.
Seminars in Radiation Oncology|April 21, 1999
Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancerC D Blanke, H Choy, M Teng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study GroupD H Johnson, L H Einhorn, R Birch, et al.
Pageof 39